Asia-Pacific Bioengineered Protein Drugs Market Report 2018

2018-06-13 / 4000.00 / Pharma & Healthcare / 118 Pages

Description

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Bioengineered Protein Drugs for these regions, from 2012 to 2023 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia

Asia-Pacific Bioengineered Protein Drugs market competition by top manufacturers/players, with Bioengineered Protein Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
GlaxoSmithKline
Johnson & Johnson
Merck
Novartis
Sanofi
Eli Lilly
F. Hoffmann-La Roche
Dr. Reddy's Laboratories
Abbott Laboratories
Amgen
Bayer AG
Biocon
Fresenius kabi
Panacea Biotec
ProBioGen AG

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Monoclonal Antibodies
Therapeutic Proteins
Vaccines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Bioengineered Protein Drugs for each application, including
Pharma and Biotech Companies
CROs
Academics

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Content

Table of Contents

Asia-Pacific Bioengineered Protein Drugs Market Report 2012-2023
1 Bioengineered Protein Drugs Overview
1.1 Product Overview and Scope of Bioengineered Protein Drugs
1.2 Classification of Bioengineered Protein Drugs by Product Category
1.2.1 Asia-Pacific Bioengineered Protein Drugs Sales (K Units) Comparison by Types (2012-2023)
1.2.2 Asia-Pacific Bioengineered Protein Drugs Sales (K Units) Market Share by Types in 2017
1.2.3 Monoclonal Antibodies
1.2.4 Therapeutic Proteins
1.2.5 Vaccines
1.3 Asia-Pacific Bioengineered Protein Drugs Market by Application/End Users
1.3.1 Asia-Pacific Bioengineered Protein Drugs (K Units) and Market Share Comparison by Applications (2012-2023)
1.3.2 Pharma and Biotech Companies
1.3.3 CROs
1.3.4 Academics
1.4 Asia-Pacific Bioengineered Protein Drugs Market by Region
1.4.1 Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) Comparison by Regions (2012-2023)
1.4.2 China Status and Prospect (2012-2023)
1.4.3 Japan Status and Prospect (2012-2023)
1.4.4 South Korea Status and Prospect (2012-2023)
1.4.5 Taiwan Status and Prospect (2012-2023)
1.4.6 India Status and Prospect (2012-2023)
1.4.7 Southeast Asia Status and Prospect (2012-2023)
1.4.8 Australia Status and Prospect (2012-2023)
1.5 Asia-Pacific Sales and Revenue ofSales and Revenue of Bioengineered Protein Drugs (2012-2023)
1.5.1 Asia-Pacific Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2023)
1.5.2 Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023)

2 Industrial Chain Analysis
2.1 Industry Chain Structure of Bioengineered Protein Drugs
2.2 Raw Material Analysis of Bioengineered Protein Drugs
2.1.1 Raw Material A Market Analysis
2.1.2 Raw Material B Market Analysis
2.1.3 Raw Material C Market Analysis
2.3 Labor Cost Analysis of K Units
2.4 Other Costs Analysis of Bioengineered Protein Drugs
2.5 Manufacturing Cost Structure Analysis of Bioengineered Protein Drugs
2.6 Manufacturing Process Analysis of Bioengineered Protein Drugs
2.7 Raw Materials Sources of Bioengineered Protein Drugs Major Manufacturers in 2018
2.8 Downstream Buyers

3 Asia-Pacific Bioengineered Protein Drugs Players/Suppliers Profiles and Sales Data
3.1 GlaxoSmithKline
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Bioengineered Protein Drugs Product Category, Application and Specification
3.1.2.1 Product A
3.1.2.2 Product B
3.1.3 GlaxoSmithKline Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.1.4 GlaxoSmithKline Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.1.5 GlaxoSmithKline Bioengineered Protein Drugs Volume in Different Applications and Its Application Share
3.2 Johnson & Johnson
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Bioengineered Protein Drugs Product Category, Application and Specification
3.2.2.1 Product A
3.2.2.2 Product B
3.2.3 Johnson & Johnson Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.2.4 Johnson & Johnson Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.2.5 Johnson & Johnson Bioengineered Protein Drugs Volume in Different Applications and Its Application Share
3.3 Merck
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Bioengineered Protein Drugs Product Category, Application and Specification
3.3.2.1 Product A
3.3.2.2 Product B
3.3.3 Merck Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.3.4 Merck Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.3.5 Merck Bioengineered Protein Drugs Volume in Different Applications and Its Application Share
3.4 Novartis
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Bioengineered Protein Drugs Product Category, Application and Specification
3.4.2.1 Product A
3.4.2.2 Product B
3.4.3 Novartis Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.4.4 Novartis Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.4.5 Novartis Bioengineered Protein Drugs Volume in Different Applications and Its Application Share
3.5 Sanofi
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Bioengineered Protein Drugs Product Category, Application and Specification
3.5.2.1 Product A
3.5.2.2 Product B
3.5.3 Sanofi Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.5.4 Sanofi Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.5.5 Sanofi Bioengineered Protein Drugs Volume in Different Applications and Its Application Share
3.6 Eli Lilly
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Bioengineered Protein Drugs Product Category, Application and Specification
3.6.2.1 Product A
3.6.2.2 Product B
3.6.3 Eli Lilly Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.6.4 Eli Lilly Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.6.5 Eli Lilly Bioengineered Protein Drugs Volume in Different Applications and Its Application Share
3.7 F. Hoffmann-La Roche
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Bioengineered Protein Drugs Product Category, Application and Specification
3.7.2.1 Product A
3.7.2.2 Product B
3.7.3 F. Hoffmann-La Roche Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.7.4 F. Hoffmann-La Roche Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.7.5 F. Hoffmann-La Roche Bioengineered Protein Drugs Volume in Different Applications and Its Application Share
3.8 Dr. Reddy's Laboratories
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Bioengineered Protein Drugs Product Category, Application and Specification
3.8.2.1 Product A
3.8.2.2 Product B
3.8.3 Dr. Reddy's Laboratories Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.8.4 Dr. Reddy's Laboratories Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.8.5 Dr. Reddy's Laboratories Bioengineered Protein Drugs Volume in Different Applications and Its Application Share
3.9 Abbott Laboratories
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Bioengineered Protein Drugs Product Category, Application and Specification
3.9.2.1 Product A
3.9.2.2 Product B
3.9.3 Abbott Laboratories Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.9.4 Abbott Laboratories Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.9.5 Abbott Laboratories Bioengineered Protein Drugs Volume in Different Applications and Its Application Share
3.10 Amgen
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Bioengineered Protein Drugs Product Category, Application and Specification
3.10.2.1 Product A
3.10.2.2 Product B
3.10.3 Amgen Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.10.4 Amgen Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.10.5 Amgen Bioengineered Protein Drugs Volume in Different Applications and Its Application Share
3.11 Bayer AG
3.12 Biocon
3.13 Fresenius kabi
3.14 Panacea Biotec
3.15 ProBioGen AG

4 Asia-Pacific Bioengineered Protein Drugs Competition by Players/Manufacturers, Region, Type and Application
4.1 Asia-Pacific Bioengineered Protein Drugs Market Competition by Players/Manufacturers
4.1.1 Asia-Pacific Bioengineered Protein Drugs Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017)
4.1.2 Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) and Share by Players/Suppliers (2012-2017)
4.2 Asia-Pacific Bioengineered Protein Drugs Sales and Revenue by Type
4.2.1 Asia-Pacific Bioengineered Protein Drugs Sales (K Units) and Market Share by Type (2012-2017)
4.2.2 Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 Asia-Pacific Bioengineered Protein Drugs Sales and Revenue by Application
4.3.1 Asia-Pacific Bioengineered Protein Drugs Sales (K Units) and Market Share by Regions (2012-2017)
4.3.2 Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) and Market Share (%) Regions (2012-2017)
4.4 Asia-Pacific Bioengineered Protein Drugs Sales (K Units) by Application

5 China Bioengineered Protein Drugs (Sales, Revenue and Price)
5.1 China Bioengineered Protein Drugs Sales and Value (2012-2017)
5.1.1 China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017)
5.1.2 China Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
5.1.3 China Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017)
5.2 China Bioengineered Protein Drugs Sales (K Units) and Market Share by Type
5.3 China Bioengineered Protein Drugs Sales (K Units) and Market Share by Application

6 Japan Bioengineered Protein Drugs (Sales, Revenue and Price)
6.1 Japan Bioengineered Protein Drugs Sales and Value (2012-2017)
6.1.1 Japan Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017)
6.1.2 Japan Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
6.1.3 Japan Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017)
6.2 Japan Bioengineered Protein Drugs Sales (K Units) and Market Share by Type
6.3 Japan Bioengineered Protein Drugs Sales (K Units) and Market Share by Application

7 South Korea Bioengineered Protein Drugs (Sales, Revenue and Price)
7.1 South Korea Bioengineered Protein Drugs Sales and Value (2012-2017)
7.1.1 South Korea Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017)
7.1.2 South Korea Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
7.1.3 South Korea Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017)
7.2 South Korea Bioengineered Protein Drugs Sales (K Units) and Market Share by Type
7.3 South Korea Bioengineered Protein Drugs Sales (K Units) and Market Share by Application

8 Taiwan Bioengineered Protein Drugs (Sales, Revenue and Price)
8.1 Taiwan Bioengineered Protein Drugs Sales and Value (2012-2017)
8.1.1 Taiwan Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017)
8.1.2 Taiwan Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
8.1.3 Taiwan Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017)
8.2 Taiwan Bioengineered Protein Drugs Sales (K Units) and Market Share by Type
8.3 Taiwan Bioengineered Protein Drugs Sales (K Units) and Market Share by Application

9 India Bioengineered Protein Drugs (Sales, Revenue and Price)
9.1 India Bioengineered Protein Drugs Sales and Value (2012-2017)
9.1.1 India Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017)
9.1.2 India Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
9.1.3 India Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017)
9.2 India Bioengineered Protein Drugs Sales (K Units) and Market Share by Type
9.3 India Bioengineered Protein Drugs Sales (K Units) and Market Share by Application

10 Southeast Asia Bioengineered Protein Drugs (Sales, Revenue and Price)
10.1 Southeast Asia Bioengineered Protein Drugs Sales and Value (2012-2017)
10.1.1 Southeast Asia Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017)
10.1.2 Southeast Asia Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
10.1.3 Southeast Asia Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017)
10.2 Southeast Asia Bioengineered Protein Drugs Sales (K Units) and Market Share by Type
10.3 Southeast Asia Bioengineered Protein Drugs Sales (K Units) and Market Share by Application

11 Australia Bioengineered Protein Drugs (Sales, Revenue and Price)
11.1 Australia Bioengineered Protein Drugs Sales and Value (2012-2017)
11.1.1 Australia Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017)
11.1.2 Australia Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
11.1.3 Australia Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017)
11.2 Australia Bioengineered Protein Drugs Sales (K Units) and Market Share by Type
11.3 Australia Bioengineered Protein Drugs Sales (K Units) and Market Share by Application

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Direct Marketing
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Asia-Pacific Bioengineered Protein Drugs Market Forecast (2018-2023)
13.1 Asia-Pacific Bioengineered Protein Drugs Sales (K Units), Revenue and Price Forecast (2018-2023)
13.1.1 Asia-Pacific Bioengineered Protein Drugs Sales (K Units) and Growth Rate Forecast (2018-2023)
13.1.2 Asia-Pacific Bioengineered Protein Drugs Revenue and Growth Rate Forecast (2018-2023)
13.1.3 Asia-Pacific Bioengineered Protein Drugs Price and Trend Forecast (2018-2023)
13.2 Asia-Pacific Bioengineered Protein Drugs Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023)
13.2.1 Asia-Pacific Bioengineered Protein Drugs Sales (K Units) and Growth Rate Forecast by Region (2018-2023)
13.2.2 Asia-Pacific Bioengineered Protein Drugs Revenue and Growth Rate Forecast by Region (2018-2023)
13.2.3 China Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.4 Japan Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.5 South Korea Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.6 Taiwan Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.7 South Korea Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.8 Southeast Asia Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.9 Australia Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023)
13.3 Asia-Pacific Bioengineered Protein Drugs Sales, Revenue and Price Forecast by Type (2018-2023)
13.3.1 Asia-Pacific Bioengineered Protein Drugs Sales Forecast by Type (2018-2023)
13.3.2 Asia-Pacific Bioengineered Protein Drugs Revenue Forecast by Type (2018-2023)
13.3.3 Asia-Pacific Bioengineered Protein Drugs Price Forecast by Type (2018-2023)
13.4 Asia-Pacific Bioengineered Protein Drugs Sales Forecast by Application (2018-2023)

14 Research Findings and Conclusion

15 Appendix
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Disclaimer



Table of Figures

List of Tables and Figures

Figure Asia-Pacific Market Size (Million USD) Comparison 2012-2023
Table Asia-Pacific Market Bioengineered Protein Drugs Revenue (Million USD) Comparison by Regions 2012-2023
Table Asia-Pacific Bioengineered Protein Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Asia-Pacific Bioengineered Protein Drugs Sales (K Units) by Application (2016-2023)
Figure Product Picture of Bioengineered Protein Drugs
Table Asia-Pacific Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023)
Figure Asia-Pacific Bioengineered Protein Drugs Sales (K Units) Market Share by Types in 2017
Figure Monoclonal Antibodies Picture
Figure Therapeutic Proteins Picture
Figure Vaccines Picture
Table Asia-Pacific Bioengineered Protein Drugs Sales (K Units) Comparison by Applications (2012-2023)
Figure Asia-Pacific Sales Market Share of Bioengineered Protein Drugs by Applications in 2017
Figure Pharma and Biotech Companies Picture
Figure CROs Picture
Figure Academics Picture
Table Asia-Pacific Market Bioengineered Protein Drugs Revenue (Million USD) Comparison by Regions 2012-2023
Figure China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023)
Figure Japan Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023)
Figure South Korea Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023)
Figure Taiwan Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023)
Figure India Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023)
Figure Southeast Asia Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023)
Figure Australia Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023)
Figure Asia-Pacific Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2023)
Figure Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023)
Figure New Project SWOT Analysis of Bioengineered Protein Drugs
Table Industry News List of Bioengineered Protein Drugs
Figure Industry Chain Structure of Bioengineered Protein Drugs
Table Raw Material Suppliers and Price Analysis
Figure Global Raw Material A Price Trend (USD/MT)
Figure Global Raw Material B Price Trend (USD/MT)
Figure Global Raw Material C Price Trend (USD/MT)
Table Manufacturing Cost Structure Analysis of Bioengineered Protein Drugs in 2017
Figure Manufacturing Process Analysis of Bioengineered Protein Drugs
Table Raw Materials Sources of Bioengineered Protein Drugs Major Manufacturers in 2017
Table Major Buyers of Bioengineered Protein Drugs
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure GlaxoSmithKline Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Bioengineered Protein Drugs Sales Asia-Pacific Market Share (%) (2012-2017)
Figure GlaxoSmithKline Bioengineered Protein Drugs Revenue Asia-Pacific Market Share (%) (2012-2017)
Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table GlaxoSmithKline Bioengineered Protein Drugs Volume in Pharma and Biotech Companies and Its Application Share
Table GlaxoSmithKline Bioengineered Protein Drugs Volume in CROs and Its Application Share
Table GlaxoSmithKline Bioengineered Protein Drugs Volume in Academics and Its Application Share
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Johnson & Johnson Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Bioengineered Protein Drugs Sales Asia-Pacific Market Share (%) (2012-2017)
Figure Johnson & Johnson Bioengineered Protein Drugs Revenue Asia-Pacific Market Share (%) (2012-2017)
Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Johnson & Johnson Bioengineered Protein Drugs Volume in Pharma and Biotech Companies and Its Application Share
Table Johnson & Johnson Bioengineered Protein Drugs Volume in CROs and Its Application Share
Table Johnson & Johnson Bioengineered Protein Drugs Volume in Academics and Its Application Share
Table Merck Basic Information List
Table Merck Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Merck Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure Merck Bioengineered Protein Drugs Sales Asia-Pacific Market Share (%) (2012-2017)
Figure Merck Bioengineered Protein Drugs Revenue Asia-Pacific Market Share (%) (2012-2017)
Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Merck Bioengineered Protein Drugs Volume in Pharma and Biotech Companies and Its Application Share
Table Merck Bioengineered Protein Drugs Volume in CROs and Its Application Share
Table Merck Bioengineered Protein Drugs Volume in Academics and Its Application Share
Table Novartis Basic Information List
Table Novartis Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Novartis Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure Novartis Bioengineered Protein Drugs Sales Asia-Pacific Market Share (%) (2012-2017)
Figure Novartis Bioengineered Protein Drugs Revenue Asia-Pacific Market Share (%) (2012-2017)
Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Novartis Bioengineered Protein Drugs Volume in Pharma and Biotech Companies and Its Application Share
Table Novartis Bioengineered Protein Drugs Volume in CROs and Its Application Share
Table Novartis Bioengineered Protein Drugs Volume in Academics and Its Application Share
Table Sanofi Basic Information List
Table Sanofi Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Sanofi Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure Sanofi Bioengineered Protein Drugs Sales Asia-Pacific Market Share (%) (2012-2017)
Figure Sanofi Bioengineered Protein Drugs Revenue Asia-Pacific Market Share (%) (2012-2017)
Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Sanofi Bioengineered Protein Drugs Volume in Pharma and Biotech Companies and Its Application Share
Table Sanofi Bioengineered Protein Drugs Volume in CROs and Its Application Share
Table Sanofi Bioengineered Protein Drugs Volume in Academics and Its Application Share
Table Eli Lilly Basic Information List
Table Eli Lilly Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Eli Lilly Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure Eli Lilly Bioengineered Protein Drugs Sales Asia-Pacific Market Share (%) (2012-2017)
Figure Eli Lilly Bioengineered Protein Drugs Revenue Asia-Pacific Market Share (%) (2012-2017)
Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Eli Lilly Bioengineered Protein Drugs Volume in Pharma and Biotech Companies and Its Application Share
Table Eli Lilly Bioengineered Protein Drugs Volume in CROs and Its Application Share
Table Eli Lilly Bioengineered Protein Drugs Volume in Academics and Its Application Share
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure F. Hoffmann-La Roche Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Bioengineered Protein Drugs Sales Asia-Pacific Market Share (%) (2012-2017)
Figure F. Hoffmann-La Roche Bioengineered Protein Drugs Revenue Asia-Pacific Market Share (%) (2012-2017)
Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table F. Hoffmann-La Roche Bioengineered Protein Drugs Volume in Pharma and Biotech Companies and Its Application Share
Table F. Hoffmann-La Roche Bioengineered Protein Drugs Volume in CROs and Its Application Share
Table F. Hoffmann-La Roche Bioengineered Protein Drugs Volume in Academics and Its Application Share
Table Dr. Reddy's Laboratories Basic Information List
Table Dr. Reddy's Laboratories Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Dr. Reddy's Laboratories Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure Dr. Reddy's Laboratories Bioengineered Protein Drugs Sales Asia-Pacific Market Share (%) (2012-2017)
Figure Dr. Reddy's Laboratories Bioengineered Protein Drugs Revenue Asia-Pacific Market Share (%) (2012-2017)
Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Dr. Reddy's Laboratories Bioengineered Protein Drugs Volume in Pharma and Biotech Companies and Its Application Share
Table Dr. Reddy's Laboratories Bioengineered Protein Drugs Volume in CROs and Its Application Share
Table Dr. Reddy's Laboratories Bioengineered Protein Drugs Volume in Academics and Its Application Share
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Abbott Laboratories Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure Abbott Laboratories Bioengineered Protein Drugs Sales Asia-Pacific Market Share (%) (2012-2017)
Figure Abbott Laboratories Bioengineered Protein Drugs Revenue Asia-Pacific Market Share (%) (2012-2017)
Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Abbott Laboratories Bioengineered Protein Drugs Volume in Pharma and Biotech Companies and Its Application Share
Table Abbott Laboratories Bioengineered Protein Drugs Volume in CROs and Its Application Share
Table Abbott Laboratories Bioengineered Protein Drugs Volume in Academics and Its Application Share
Table Company Amgen Basic Information List
Table Company Amgen Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Company Amgen Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure Company Amgen Bioengineered Protein Drugs Sales Asia-Pacific Market Share (%) (2012-2017)
Figure Company Amgen Bioengineered Protein Drugs Revenue Asia-Pacific Market Share (%) (2012-2017)
Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Company Amgen Bioengineered Protein Drugs Volume in Pharma and Biotech Companies and Its Application Share
Table Company Amgen Bioengineered Protein Drugs Volume in CROs and Its Application Share
Table Company Amgen Bioengineered Protein Drugs Volume in Academics and Its Application Share
Table Asia-Pacific Bioengineered Protein Drugs Sales (K Units) by Players/Manufacturers (2012-2017)
Table Asia-Pacific Bioengineered Protein Drugs Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 Asia-Pacific Bioengineered Protein Drugs Sales Market Share (%) by Players/Manufacturers
Figure 2017 Asia-Pacific Bioengineered Protein Drugs Sales Share by Players/Manufacturers
Table Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) by Players/Manufacturers (2012-2017)
Table Asia-Pacific Bioengineered Protein Drugs Revenue Market Share (%) Players/Manufacturers (2012-2017)
Figure 2016 Asia-Pacific Bioengineered Protein Drugs Revenue Market Share (%) Players
Figure 2017 Asia-Pacific Bioengineered Protein Drugs Revenue Market Share (%) Players
Table Asia-Pacific Bioengineered Protein Drugs Sales (K Units) and Market Share (%) by Type (2012-2017)
Table Asia-Pacific Bioengineered Protein Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Bioengineered Protein Drugs by Type (2012-2017)
Figure Asia-Pacific Bioengineered Protein Drugs Sales Growth Rate (%) by Type (2012-2017)
Table Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) and Market Share (%) Type (2012-2017)
Table Asia-Pacific Bioengineered Protein Drugs Revenue Market Share (%) Type (2012-2017)
Figure Revenue Market Share of Bioengineered Protein Drugs by Type (2012-2017)
Figure Asia-Pacific Bioengineered Protein Drugs Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Bioengineered Protein Drugs Sales (K Units) and Market Share by Regions (2012-2017)
Table Asia-Pacific Bioengineered Protein Drugs Sales Share by Regions (2012-2017)
Figure Sales Market Share of Bioengineered Protein Drugs by Regions (2012-2017)
Figure Asia-Pacific Bioengineered Protein Drugs Sales Market Share by Regions in 2017
Table Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) and Market Share by Regions (2012-2017)
Table Asia-Pacific Bioengineered Protein Drugs Revenue Share (%) by Regions (2012-2017)
Figure Revenue Market Share of Bioengineered Protein Drugs by Regions (2012-2017)
Figure Asia-Pacific Bioengineered Protein Drugs Revenue Market Share by Regions in 2017
Table Asia-Pacific Bioengineered Protein Drugs Sales (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific Bioengineered Protein Drugs Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Bioengineered Protein Drugs Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Bioengineered Protein Drugs Sales Market Share by Application (2012-2017)
Figure China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) (2012-2017)
Figure China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure China Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table China Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017)
Table China Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017)
Figure China Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017
Table China Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017)
Table China Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017)
Figure China Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017
Figure Japan Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Japan Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017)
Table Japan Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017)
Figure Japan Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017
Table Japan Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017)
Table Japan Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017)
Figure Japan Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017
Figure South Korea Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure South Korea Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017)
Table South Korea Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017)
Figure South Korea Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017
Table South Korea Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017)
Table South Korea Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017)
Figure South Korea Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017
Figure Taiwan Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Taiwan Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017)
Table Taiwan Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017)
Figure Taiwan Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017
Table Taiwan Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017)
Table Taiwan Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017)
Figure Taiwan Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017
Figure Southeast Asia Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Southeast Asia Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017)
Table Southeast Asia Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017)
Figure Southeast Asia Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017
Table Southeast Asia Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017)
Table Southeast Asia Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017)
Figure Southeast Asia Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017
Figure India Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure India Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure India Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table India Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017)
Table India Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017)
Figure India Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017
Table India Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017)
Table India Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017)
Figure India Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017
Figure Australia Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Australia Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Australia Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Australia Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017)
Table Australia Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017)
Figure Australia Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017
Table Australia Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017)
Table Australia Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017)
Figure Australia Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017
Table Distributors/Traders List
Figure Asia-Pacific Bioengineered Protein Drugs Sales (K Units) and Growth Rate Forecast (2018-2023)
Figure Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure Asia-Pacific Bioengineered Protein Drugs Price and Trend Forecast (2018-2023)
Table Asia-Pacific Bioengineered Protein Drugs Sales (K Units) Forecast by Regions (2018-2023)
Figure Asia-Pacific Bioengineered Protein Drugs Sales (K Units) Market Share Forecast by Regions (2018-2023)
Figure Asia-Pacific Bioengineered Protein Drugs Sales (K Units) Market Share Forecast by Regions in 2023
Table Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Asia-Pacific Bioengineered Protein Drugs Revenue Market Share Forecast by Regions (2018-2023)
Figure Asia-Pacific Bioengineered Protein Drugs Revenue Market Share Forecast by Regions in 2023
Figure China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure South Korea Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure South Korea Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure Japan Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure Japan Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure Taiwan Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure Taiwan Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure India Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure India Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure Southeast Asia Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure Southeast Asia Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure Australia Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure Australia Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Table Asia-Pacific Bioengineered Protein Drugs Sales (K Units) Forecast by Type (2018-2023)
Figure Asia-Pacific Bioengineered Protein Drugs Sales Market Share Forecast by Type (2018-2023)
Table Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) Forecast by Type (2018-2023)
Figure Asia-Pacific Bioengineered Protein Drugs Revenue Market Share Forecast by Type (2018-2023)
Table Asia-Pacific Bioengineered Protein Drugs Price (USD/Unit) Forecast by Type (2018-2023)
Table Asia-Pacific Bioengineered Protein Drugs Sales (K Units) Forecast by Application (2018-2023)
Figure Asia-Pacific Bioengineered Protein Drugs Sales Market Share Forecast by Application (2018-2023)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources










Request Sample

* mark fields are compulsory